Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Yapan Bio

Tracked across 5 events · 61 articles · First seen Apr 28, 2026 · Last active Aug 18, 2026

Sentiment
10
Attention
4
Events
5
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 50
Business
Impact: Target; became a subsidiary of Piramal Pharma, gaining access to broader resources and integration into PPL's global network.
Jul 20, 2026 · 11 articles
4 0
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in the biologics/bio-therapeutics and vaccine segments.
Apr 28, 2026 · 14 articles
2 0
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in biologics and vaccines.
Jul 07, 2026 · 14 articles
2 0
Business
Impact: Associate company of Piramal Pharma; not directly involved in this expansion.
Aug 04, 2026 · 12 articles
2 0
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in biologics and vaccine segments.
Jul 29, 2026 · 10 articles
ERGEN INTELLIGENCE
Track Yapan Bio live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.